Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
---|
12/24/2013 | CA2621360C Ring-closing metathesis process for the preparation of macrocyclic peptides |
12/24/2013 | CA2616954C Macrocyclic inhibitors of hepatitis c virus |
12/24/2013 | CA2609812C Angiotensin i-converting enzyme (ace) inhibitors |
12/24/2013 | CA2609558C Identification of compounds modifying a cellular response |
12/19/2013 | WO2013188607A1 One step n-terminal tagging of proteins |
12/19/2013 | US20130338085 Mucin hypersecretion inhibitors and methods of use |
12/19/2013 | US20130338076 Peptides and methods using same for diagnosis and treatment of amyloid-associated disease |
12/19/2013 | US20130338075 Methods and compositions for the treatment of axonal and neuronal degeneration |
12/19/2013 | US20130338062 Hcv protease inhibitors and uses thereof |
12/19/2013 | US20130338057 Compounds for enzyme inhibition |
12/19/2013 | US20130337028 Biomimetic peptides for bone augmentation |
12/18/2013 | EP2673288A1 Peptide for use in the treatment of skin conditions |
12/18/2013 | EP2673287A1 Amino statin derivatives for the treatment of arthrosis |
12/18/2013 | EP2672989A1 Immunogenic composition comprising alpha-hemolysin oligopeptides |
12/18/2013 | EP2333118B1 Method for rapid detection and identification of bioagents |
12/18/2013 | EP2322649B1 Method for rapid detection and identification of bioagents |
12/18/2013 | CN103459409A Process for producing reduced glutathione |
12/18/2013 | CN103450335A Beta-carboline acyl tryptophyl tryptophan amino acid benzyl ester, as well as synthesis, anti-tumor action and application thereof |
12/18/2013 | CN103450334A RGD peptide-modified carbolino-hexahydropyrazine-1,4-diketones and their preparation method, antithrombotic effect and use |
12/18/2013 | CN103450333A 1,1-dimethyl-beta-carboline carboxylic acid-modified RGD peptides and their synthesis, anti-thrombus effect and use |
12/18/2013 | CN103450332A Styrene-beta-carboline-modified tripeptide benzyl ester, as well as preparation, anti-tumor activity and application thereof |
12/18/2013 | CN103450331A Method for refining bortezomib |
12/18/2013 | CN103450330A Dihydroxyltetrahydroisoquinoline-3-formyl amino acids as well as synthesis, antithrombotic effect and application thereof |
12/18/2013 | CN103450329A 3H-imidazo[4,5-c]pyridine-6-formyl-amido acid benzyl esters and their synthesis, anti-tumor activity and use |
12/18/2013 | CN103450196A AGDV peptide modified carboline-hexahydropyrazine-1,4-dione, preparation method, antithrombotic effect, and applications thereof |
12/17/2013 | US8609809 Bis-sulfhydryl macrocyclization systems |
12/17/2013 | US8609610 Inhibitors of the trypsin-like site of the proteasome and methods of use thereof |
12/17/2013 | US8609607 Modified defensins and their use |
12/17/2013 | US8609404 Vaccines containing canine parvovirus genetic variants |
12/17/2013 | US8609065 Molecules for targeting compounds to various selected organs, tissues or tumor cells |
12/12/2013 | WO2013185090A1 Macrocyclic inhibitors of flaviviridae viruses |
12/12/2013 | WO2013184962A1 Chimeric fibroblast growth factor 19 proteins and methods of use |
12/12/2013 | WO2013184958A1 Chimeric fibroblast growth factor 21 proteins and methods of use |
12/12/2013 | US20130331547 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury |
12/12/2013 | US20130331328 Small molecule inhibitors of agbl2 |
12/12/2013 | US20130331310 Prodrug of an Ice Inhibitor |
12/12/2013 | CA2875790A1 Chimeric fibroblast growth factor 21 proteins and methods of use |
12/12/2013 | CA2875718A1 Macrocyclic inhibitors of flaviviridae viruses |
12/11/2013 | EP2671954A2 Translocation and mutant ROS kinase in human non-small cell lung carcinoma |
12/11/2013 | EP2671889A2 RF amide-related peptides and methods thereof |
12/11/2013 | EP2670766A1 Novel peptides involved in the scf c-kit signalling pathway and compositions comprising same |
12/11/2013 | CN103443118A Novel peptide |
12/11/2013 | CN103435681A Preparation method of pigment tripeptide |
12/11/2013 | CN103435638A Boronate ester compounds and pharmaceutical compositions thereof |
12/11/2013 | CN102731613B Preparation method of L-alanyl-L-glutamine |
12/11/2013 | CN102093467B Dipeptide iron chelate for feed additives and preparation method thereof |
12/11/2013 | CN101636408B 肽 Peptide |
12/10/2013 | US8604167 CD133 epitopes |
12/10/2013 | US8604164 High purity lipopeptides |
12/10/2013 | US8604161 Prion protein ligands and methods of use |
12/10/2013 | US8603971 Methods for reducing CD36 expression |
12/10/2013 | US8603455 Removal promoters and inhibitor for apoptosis cells in vivo |
12/10/2013 | CA2552317C Hcv ns-3 serine protease inhibitors |
12/05/2013 | WO2013178682A2 Multicomponent process for the preparation of bicyclic compounds |
12/05/2013 | US20130324706 Branched Linker for Protein Drug Conjugates |
12/05/2013 | US20130324459 Compounds For Enzyme Inhibition |
12/05/2013 | CA2874828A1 Modulation of hepatitis b virus cccdna transcription |
12/04/2013 | CN103421083A Anti-dengue virus heterocycle peptide compounds having 1,2,3-triazole structure, preparation method and use thereof |
12/04/2013 | CN103420991A Pyrrolidine derivative used as hepatitis c inhibitor and application thereof in medicine |
12/04/2013 | CN102477066B N-(S-1,2,3,4-tetrahydro-6,7-dihydroxyisoquinolyl-3-formyl)amino acid, synthetic method thereof, and application thereof |
12/04/2013 | CN101663314B Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
12/04/2013 | CN101553463B New pharmaceutical intermediates in the synthesis of ace- inhibitors and the use thereof |
12/03/2013 | US8598314 Peptide-peptidase-inhibitor conjugates and methods of making and using same |
12/03/2013 | US8598312 Inhibitors of antigen presentation by MHC class II molecules |
12/03/2013 | US8598126 Peptides for inhibiting the HPV-E6 oncoprotein |
12/03/2013 | US8598124 Peptides derived from HMG-CoA reductase and cosmetic and/or pharmaceutical composition containing same |
12/03/2013 | CA2566481C Peptides or peptidic conjugate derivatives of msh and the use thereof for cosmetically fighting against canities |
11/28/2013 | WO2013177293A1 Trapping reagents for reactive metabolites screening |
11/28/2013 | US20130316964 Aromatic-cationic peptides and uses of same |
11/28/2013 | US20130316955 Aminostatin derivatives for the treatment of arthrosis |
11/28/2013 | US20130316953 New uses for amino acid anticonvulsants |
11/28/2013 | US20130316945 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
11/28/2013 | US20130316943 Boron containing polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
11/28/2013 | US20130316942 Antioxidant, Anti-Inflammatory, Anti-Radiation, Metal Chelating Compounds And Uses Thereof |
11/27/2013 | EP2665742A2 Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof |
11/27/2013 | CN103415621A Aldehyde-tagged immunoglobulin polypeptides and method of use thereof |
11/27/2013 | CN103415532A Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof |
11/27/2013 | CN103415531A Peptide for use in the treatment of skin conditions |
11/27/2013 | CN103408765A C3 polypeptide supramolecular helical polymer and preparation method thereof |
11/27/2013 | CN103408636A Preparation method of bortezomib |
11/27/2013 | CN103408635A Method for synthesizing mifamurtide |
11/27/2013 | CN103059099B Novel pidotimod crystal form and preparation method thereof |
11/27/2013 | CN102558298B Method for synthesizing tetrapeptide isomers by using solid phase peptide synthesis method and applications of tetrapeptide isomers |
11/27/2013 | CN102209776B Detergent composition |
11/27/2013 | CN102197044B Peptide having anti-diabetic activity and use thereof |
11/26/2013 | US8592379 Metastin derivative and use thereof |
11/26/2013 | US8592377 Stitched polypeptides |
11/26/2013 | US8591907 Hypoallergenic variants of the major allergen from Betula verrucosa pollen |
11/26/2013 | US8591878 Therapeutic compounds |
11/26/2013 | CA2623652C Antibody-drug conjugates and methods of use |
11/21/2013 | WO2013172728A1 Agent for correcting metabolic syndrome |
11/21/2013 | WO2013171595A1 Novel compounds and methods for inhibiting cell death |
11/21/2013 | US20130310320 Boronic ester and acid compounds, synthesis and uses |
11/21/2013 | US20130310311 Novel selective inhibitors of prolylcarboxypeptidase |
11/21/2013 | US20130309247 Dimeric iap inhibitors |
11/20/2013 | EP2664621A1 Antiviral agent |
11/20/2013 | EP2663647A2 Aldehyde-tagged immunoglobulin polypeptides and method of use thereof |
11/20/2013 | EP2108655B1 Immune-modulating peptide |
11/20/2013 | EP2041156B1 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication |
11/20/2013 | CN103403018A Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa |